SubHero Banner
Text

Laboratory analysis of ranitidine and nizatidine products – Safety update

December 4, 2019 - The FDA announced that they are asking manufacturers of ranitidine and nizatidine products to expand their testing for the N-nitrosodimethylamine (NDMA) impurity, to include all lots of the medication before making them available to consumers.

Download PDF